These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

300 related items for PubMed ID: 10904086

  • 1. 15-LOX-1: a novel molecular target of nonsteroidal anti-inflammatory drug-induced apoptosis in colorectal cancer cells.
    Shureiqi I, Chen D, Lee JJ, Yang P, Newman RA, Brenner DE, Lotan R, Fischer SM, Lippman SM.
    J Natl Cancer Inst; 2000 Jul 19; 92(14):1136-42. PubMed ID: 10904086
    [Abstract] [Full Text] [Related]

  • 2. 15-Lipoxygenase-1 mediates nonsteroidal anti-inflammatory drug-induced apoptosis independently of cyclooxygenase-2 in colon cancer cells.
    Shureiqi I, Chen D, Lotan R, Yang P, Newman RA, Fischer SM, Lippman SM.
    Cancer Res; 2000 Dec 15; 60(24):6846-50. PubMed ID: 11156377
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The 15-lipoxygenase-1 product 13-S-hydroxyoctadecadienoic acid down-regulates PPAR-delta to induce apoptosis in colorectal cancer cells.
    Shureiqi I, Jiang W, Zuo X, Wu Y, Stimmel JB, Leesnitzer LM, Morris JS, Fan HZ, Fischer SM, Lippman SM.
    Proc Natl Acad Sci U S A; 2003 Aug 19; 100(17):9968-73. PubMed ID: 12909723
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. GATA-6 transcriptional regulation of 15-lipoxygenase-1 during NSAID-induced apoptosis in colorectal cancer cells.
    Shureiqi I, Jiang W, Fischer SM, Xu X, Chen D, Lee JJ, Lotan R, Lippman SM.
    Cancer Res; 2002 Feb 15; 62(4):1178-83. PubMed ID: 11861401
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Decreased 13-S-hydroxyoctadecadienoic acid levels and 15-lipoxygenase-1 expression in human colon cancers.
    Shureiqi I, Wojno KJ, Poore JA, Reddy RG, Moussalli MJ, Spindler SA, Greenson JK, Normolle D, Hasan AA, Lawrence TS, Brenner DE.
    Carcinogenesis; 1999 Oct 15; 20(10):1985-95. PubMed ID: 10506115
    [Abstract] [Full Text] [Related]

  • 9. The 15-lipoxygenase-1 expression may enhance the sensitivity to non-steroidal anti-inflammatory drug-induced apoptosis in colorectal cancers from patients who are treated with the compounds.
    Yoshinaga M, Murao H, Kitamura Y, Koga K, Tsuruta S, Igarashi H, Nakamura K, Takayanagi R.
    J Gastroenterol Hepatol; 2007 Dec 15; 22(12):2324-9. PubMed ID: 17559385
    [Abstract] [Full Text] [Related]

  • 10. A cyclooxygenase-2 (COX-2) selective non-steroidal anti-inflammatory drug enhances the growth inhibitory effect of butyrate in colorectal carcinoma cells expressing COX-2 protein: regulation of COX-2 by butyrate.
    Crew TE, Elder DJ, Paraskeva C.
    Carcinogenesis; 2000 Jan 15; 21(1):69-77. PubMed ID: 10607736
    [Abstract] [Full Text] [Related]

  • 11. Antineoplastic effects of 15(S)-hydroxyeicosatetraenoic acid and 13-S-hydroxyoctadecadienoic acid in non-small cell lung cancer.
    Li MY, Yuan HL, Ko FW, Wu B, Long X, Du J, Wu J, Ng CS, Wan IY, Mok TS, Hui DS, Underwood MJ, Chen GG.
    Cancer; 2015 Sep 01; 121 Suppl 17():3130-45. PubMed ID: 26331820
    [Abstract] [Full Text] [Related]

  • 12. 12/15 Lipoxygenase regulation of colorectal tumorigenesis is determined by the relative tumor levels of its metabolite 12-HETE and 13-HODE in animal models.
    Chang J, Jiang L, Wang Y, Yao B, Yang S, Zhang B, Zhang MZ.
    Oncotarget; 2015 Feb 20; 6(5):2879-88. PubMed ID: 25576922
    [Abstract] [Full Text] [Related]

  • 13. Activation of protein kinase G up-regulates expression of 15-lipoxygenase-1 in human colon cancer cells.
    Deguchi A, Xing SW, Shureiqi I, Yang P, Newman RA, Lippman SM, Feinmark SJ, Oehlen B, Weinstein IB.
    Cancer Res; 2005 Sep 15; 65(18):8442-7. PubMed ID: 16166323
    [Abstract] [Full Text] [Related]

  • 14. Growth inhibition and induction of apoptosis in colorectal tumor cells by cyclooxygenase inhibitors.
    Richter M, Weiss M, Weinberger I, Fürstenberger G, Marian B.
    Carcinogenesis; 2001 Jan 15; 22(1):17-25. PubMed ID: 11159736
    [Abstract] [Full Text] [Related]

  • 15. Apo2L/TRAIL differentially modulates the apoptotic effects of sulindac and a COX-2 selective non-steroidal anti-inflammatory agent in Bax-deficient cells.
    He Q, Luo X, Huang Y, Sheikh MS.
    Oncogene; 2002 Sep 05; 21(39):6032-40. PubMed ID: 12203115
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The critical role of 15-lipoxygenase-1 in colorectal epithelial cell terminal differentiation and tumorigenesis.
    Shureiqi I, Wu Y, Chen D, Yang XL, Guan B, Morris JS, Yang P, Newman RA, Broaddus R, Hamilton SR, Lynch P, Levin B, Fischer SM, Lippman SM.
    Cancer Res; 2005 Dec 15; 65(24):11486-92. PubMed ID: 16357157
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Par-4, a proapoptotic gene, is regulated by NSAIDs in human colon carcinoma cells.
    Zhang Z, DuBois RN.
    Gastroenterology; 2000 Jun 15; 118(6):1012-7. PubMed ID: 10833474
    [Abstract] [Full Text] [Related]

  • 20. Nonsteroidal anti-inflammatory drugs induce colorectal cancer cell apoptosis by suppressing 14-3-3epsilon.
    Liou JY, Ghelani D, Yeh S, Wu KK.
    Cancer Res; 2007 Apr 01; 67(7):3185-91. PubMed ID: 17409426
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.